ArriVent BioPharma (AVBP) PT Raised to $45 at Citi

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. TSLA
4. NVDA
5. AWK

6. GNK
7. USO
8. ARGX
9. MU
10. RKLB

April 24, 2026 5:01 AM EDT

Price: $29.01 -1.69%

Rating Summary:
13 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22

Citi analyst Yigal Nochomovitz raised the price target on ArriVent BioPharma (NASDAQ: AVBP) to $45.00 (from $33.00) while maintaining a Buy rating.

Analyst PT Change

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!